Basic Information
ID: ALA2060038
Type: Functional
Description: Agonist activity at human GPR109a expressed in CHO cells assessed as decrease in forskolin-stimulated cAMP production by HTRF assay relative to 100 uM niacin
Organism: Homo sapiens
Cell type: CHO
Activity Charts
Bioactivity
Activity Types for Assay ALA2060038
Efficacy
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 123.11 | 0.78 | 0.78 |
| 176.18 | 0.08 | 0.08 |
| 218.26 | 1.79 | 1.79 |
| 208.22 | 0.64 | 0.64 |
| 208.22 | 0.64 | 0.64 |
| 224.28 | 1.36 | 1.36 |
| 224.28 | 1.36 | 1.36 |
| 222.24 | 1.03 | 1.03 |
| 222.24 | 1.03 | 1.03 |
| 270.29 | 2.07 | 2.07 |
| 218.26 | 1.94 | 1.94 |
| 254.29 | 2.24 | 2.24 |
| 178.19 | 1.01 | 1.01 |
| 178.19 | 1.01 | 1.01 |
| 178.19 | 1.01 | 1.01 |
| 178.19 | 1.01 | 1.01 |
| 164.16 | 0.77 | 0.77 |
| 192.22 | 1.40 | 1.40 |
| 192.22 | 1.40 | 1.40 |
| 164.16 | 0.77 | 0.77 |
| 206.25 | 1.79 | 1.79 |
| 206.25 | 1.79 | 1.79 |
| 220.27 | 2.18 | 2.18 |
| 220.27 | 2.18 | 2.18 |
| 234.30 | 2.57 | 2.57 |
| 206.25 | 1.65 | 1.65 |
| 220.27 | 2.04 | 2.04 |
| 220.27 | 2.04 | 2.04 |
| 192.22 | 1.40 | 1.40 |
| 190.20 | 1.18 | 1.18 |
| 204.23 | 1.57 | 1.57 |
| 204.23 | 1.57 | 1.57 |
| 204.23 | 1.40 | 1.40 |